Chak, Amitabh; Buttar, Navtej S; Foster, Nathan R et al. (2015) Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 13:665-72.e1-4
|
McWilliams, Annette; Tammemagi, Martin C; Mayo, John R et al. (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369:910-9
|
Steiling, Katrina; van den Berge, Maarten; Hijazi, Kahkeshan et al. (2013) A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med 187:933-42
|
Limburg, Paul J; Mandrekar, Sumithra J; Aubry, Marie Christine et al. (2013) Randomized phase II trial of sulindac for lung cancer chemoprevention. Lung Cancer 79:254-61
|
Berg, Alexander K; Mandrekar, Sumithra J; Ziegler, Katie L Allen et al. (2013) Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjects. J Clin Pharmacol 53:403-12
|
Falk, Gary W; Buttar, Navtej S; Foster, Nathan R et al. (2012) A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology 143:917-26.e1
|
Reid, Joel M; Walden, Chad A; Qin, Rui et al. (2011) Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668. Cancer Prev Res (Phila) 4:347-53
|
Limburg, Paul J; Mahoney, Michelle R; Ziegler, Katie L Allen et al. (2011) Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer Prev Res (Phila) 4:259-69
|
Reid, Joel M; Mandrekar, Sumithra J; Carlson, Elsa C et al. (2008) Comparative bioavailability of sulindac in capsule and tablet formulations. Cancer Epidemiol Biomarkers Prev 17:674-9
|